Apheresis in food allergies

Lamia Dahdah, Giovanna Leone, Mariacristina Artesani, Carla Riccardi, Oscar Mazzina

Research output: Contribution to journalReview articlepeer-review


Purpose of review: The prevalence of IgE-mediated food allergy and anaphylaxis has risen rapidly in developed countries, and countries with rapid industrialization may follow. Therapies include elimination diets, Oral ImmunoTherapy, and the administration of biologics, but high serum IgE levels may preclude their use. Consequently, decreasing IgE becomes a rational approach and could be obtained by immunoapheresis. The aim of this review is to evaluate the rationale and advantages of immunoapheresis. Recent findings: The majority of the available adsorbers remove aspecifically all classes of immunoglobulins. Recently, IgEspecific adsorbers have been approved. Data on immunoapheresis for the treatment of allergic diseases with pathologically elevated IgE levels are emerging. In atopic dermatitis, this therapy alone seems to be beneficial. IgE-selective apheresis appears to be sufficient to reduce the risk of anaphylaxis in multiple food allergy (MFA) and, when IgE titers are high, to open the way to treatment with Omalizumab. Summary: Prospective studies, with well designed protocols, are needed to assess the efficacy, tolerability, and costeffectiveness of immunoapheresis in the field of food allergy.

Original languageEnglish
Pages (from-to)227-231
Number of pages5
JournalCurrent Opinion in Allergy and Clinical Immunology
Issue number3
Publication statusPublished - Jan 1 2017


  • Anaphylaxis
  • Immunoapheresis
  • Multiple food allergy
  • Severe food allergy

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Apheresis in food allergies'. Together they form a unique fingerprint.

Cite this